284620 — Kainos Medicine Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Kainos Medicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-11,448	-16,225	-15,914	-15,239	-12,190
Depreciation
Amortisation
Non-Cash Items	3,396	7,920	1,781	-469	424
Unusual Items
Other Non-Cash Items
Changes in Working Capital	23.4	-1,700	1,574	210	905
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,608	-9,195	-11,296	-14,221	-9,709
Capital Expenditures	-1,221	-2,395	-2,465	-4,098	-207
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	3,031	-3,358	5,250	13,153	-3,872
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	1,811	-5,753	2,785	9,055	-4,079
Financing Cash Flow Items	1,024	198	—	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	25,775	14,667	9,342	-3,705	1,056
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	18,141	1,279	1,721	-8,615	-12,503